89 related articles for article (PubMed ID: 2153745)
1. In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits.
Ehrlich HJ; Esmon NL; Bang NU
J Lab Clin Med; 1990 Feb; 115(2):182-9. PubMed ID: 2153745
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
Thompson EA; Salem HH
J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
4. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
5. [The effect of heparin and thromboplastin on the half-life of 125I-protein C in the blood flow of rats].
Kogan AE; Strukova SM
Biull Eksp Biol Med; 1991 Feb; 111(2):116-8. PubMed ID: 1854945
[TBL] [Abstract][Full Text] [Related]
6. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
Bourin MC
C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of Solulin, a novel recombinant soluble human thrombomodulin analogue.
van Iersel T; Stroissnig H; Giesen P; Wemer J; Wilhelm-Ogunbiyi K
Thromb Haemost; 2011 Feb; 105(2):302-12. PubMed ID: 21103657
[TBL] [Abstract][Full Text] [Related]
8. Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.
Hatton MW; Southward SM; Serebrin SD; Kulczycky M; Blajchman MA
J Lab Clin Med; 1995 Dec; 126(6):521-9. PubMed ID: 7490511
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant activity of the novel thrombin inhibitor 1-butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl) amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride.
Okayama T; Araki S; Miyamae T; Morita Y; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Sep; 47(9):1023-6. PubMed ID: 9342415
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic and bleeding effects of a new synthetic direct thrombin inhibitor and of standard heparin in the rabbit.
Cadroy Y; Caranobe C; Bernat A; Maffrand JP; Sié P; Boneu B
Thromb Haemost; 1987 Aug; 58(2):764-7. PubMed ID: 3672429
[TBL] [Abstract][Full Text] [Related]
11. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice.
Kumada T; Dittman WA; Majerus PW
Blood; 1988 Mar; 71(3):728-33. PubMed ID: 2830928
[TBL] [Abstract][Full Text] [Related]
12. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation].
Luk'ianenko EF; Kireeva EG; Strukova SM
Biull Eksp Biol Med; 1988 Nov; 106(11):517-9. PubMed ID: 2848597
[TBL] [Abstract][Full Text] [Related]
13. In vitro anticoagulant properties of a minimum functional fragment of human thrombomodulin and in vivo demonstration of its benefit as an anticoagulant in extracorporeal circulation using a monkey model.
Suzuki M; Mohri M; Yamamoto S
Thromb Haemost; 1998 Feb; 79(2):417-22. PubMed ID: 9493601
[TBL] [Abstract][Full Text] [Related]
14. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
[TBL] [Abstract][Full Text] [Related]
15. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
16. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
17. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
Thompson EA; Salem HH
Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
[TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model.
Solis MM; Cook C; Cook J; Glaser C; Light D; Morser J; Yu SC; Fink L; Eidt JF
J Vasc Surg; 1991 Nov; 14(5):599-604. PubMed ID: 1658403
[TBL] [Abstract][Full Text] [Related]
19. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
[TBL] [Abstract][Full Text] [Related]
20. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
